Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release
- PMID: 12726729
- DOI: 10.1016/s0042-6822(02)00128-9
Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release
Abstract
The envelope glycoprotein of HIV-2 ROD10 has the intriguing ability to enhance the rate of viral particle release from infected cells. However, not all HIV-2 envelope glycoproteins are active in this regard. Indeed, we have previously noted that, despite a high degree of identity with that of ROD10, the envelope protein of the ROD14 isolate was unable to enhance virus production. In this study, site-directed mutagenesis was employed to reveal that a single naturally occurring alanine-to-threonine substitution at position 598, located in the extracellular part of the TM subunit, fully accounted for the lack of activity of the ROD14 Env in HeLa and 12D7 cells. A second mutation at position 422, substituting a lysine residue in ROD10 for an arginine in ROD14, was additionally required for efficient virus release from infected H9 cells, suggesting cell-type-specific requirements for this activity. Interestingly, the ROD14 Env protein exhibited a trans-dominant negative effect on particle release by ROD10 Env, suggesting that the viral release activity of the HIV-2 ROD envelope protein may be regulated by its ability to assemble into functional oligomeric structures.
Similar articles
-
The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.J Virol. 1996 Dec;70(12):8285-300. doi: 10.1128/JVI.70.12.8285-8300.1996. J Virol. 1996. PMID: 8970948 Free PMC article.
-
Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity.J Virol. 1999 Jan;73(1):778-82. doi: 10.1128/JVI.73.1.778-782.1999. J Virol. 1999. PMID: 9847387 Free PMC article.
-
Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.J Virol. 2016 Nov 28;90(24):11062-11074. doi: 10.1128/JVI.01451-16. Print 2016 Dec 15. J Virol. 2016. PMID: 27681141 Free PMC article.
-
A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells.J Virol. 1995 Sep;69(9):5217-27. doi: 10.1128/JVI.69.9.5217-5227.1995. J Virol. 1995. PMID: 7636963 Free PMC article.
-
Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.Viruses. 2016 Oct 14;8(10):285. doi: 10.3390/v8100285. Viruses. 2016. PMID: 27754450 Free PMC article.
Cited by
-
Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.PLoS Pathog. 2013;9(7):e1003487. doi: 10.1371/journal.ppat.1003487. Epub 2013 Jul 11. PLoS Pathog. 2013. PMID: 23853598 Free PMC article.
-
Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.PLoS Pathog. 2009 May;5(5):e1000443. doi: 10.1371/journal.ppat.1000443. Epub 2009 May 22. PLoS Pathog. 2009. PMID: 19461879 Free PMC article.
-
Enhanced antagonism of BST-2 by a neurovirulent SIV envelope.J Clin Invest. 2016 Jun 1;126(6):2295-307. doi: 10.1172/JCI83725. Epub 2016 May 9. J Clin Invest. 2016. PMID: 27159392 Free PMC article.
-
HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms.Mol Aspects Med. 2010 Oct;31(5):407-17. doi: 10.1016/j.mam.2010.08.002. Epub 2010 Sep 19. Mol Aspects Med. 2010. PMID: 20858517 Free PMC article. Review.
-
HIV accessory proteins versus host restriction factors.Curr Opin Virol. 2013 Dec;3(6):692-9. doi: 10.1016/j.coviro.2013.08.004. Epub 2013 Nov 15. Curr Opin Virol. 2013. PMID: 24246762 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources